Moneycontrol
HomeNewsBusinessEconomyIndia's GDP growth for January-March quarter slows to 3.1%, FY20 at 4.2%
Trending Topics

India's GDP growth for January-March quarter slows to 3.1%, FY20 at 4.2%

Agriculture, government spending drove economic growth in the March quarter; manufacturing and construction shrink, consumption growth falls to 2.7%

May 29, 2020 / 21:32 IST
Story continues below Advertisement

India's gross domestic product (GDP) grew 3.1 percent during January-March this year, as the COVID-19 induced disruptions appeared to have devastated the broader economy, pummelled by collapsing household spending and shuttered businesses that are battling to stay afloat.

The GDP growth for FY2019-20 came in at 4.2 percent, against 6.1 percent in FY 2018-19.

Story continues below Advertisement

It could get worse as restrictions and lockdowns continue to constrain people's movement, severely hurting economic activity. The nationwide lockdown kicked in from March 25, and its actual impact on the economy will show up in the subsequent months when businesses screeched to a standstill.

At 3.1 percent, India’s “real” or inflation-adjusted GDP growth was the lowest in 44 quarters, national income data released by the Central Statistics Office (CSO) on May 29, showed. Asia’s third-largest economy, which was the engine of global growth until recently, was staring at the possibility of slipping into a full-blown recession, the first time in 41 years.
An economy is often described to be in a recession when real GDP contracts in two successive quarters.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show